Atopic dermatitis is an important comorbidity in severe asthma

Ann Allergy Asthma Immunol. 2018 Jun;120(6):661-662. doi: 10.1016/j.anai.2018.02.026. Epub 2018 Feb 26.

Authors

Jason K Lee¹, Duhyun Han²

Affiliations

¹ Toronto Allergists, Evidence Based Medical Educator Inc, Canadian Society of Clinical Immunology and Allergy, Toronto, Ontario, Canada. Electronic address: jason.k.lee.md@gmail.com.
² Department of Pharmacology & Toxicology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

PMID: 29496463
DOI: 10.1016/j.anai.2018.02.026

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Anti-Allergic Agents / therapeutic use*
Antibodies, Monoclonal, Humanized / therapeutic use*
Asthma / drug therapy
Asthma / epidemiology*
Asthma / immunology
Asthma / pathology
Calcineurin Inhibitors / therapeutic use
Canada / epidemiology
Comorbidity
Dermatitis, Atopic / drug therapy
Dermatitis, Atopic / epidemiology*
Dermatitis, Atopic / immunology
Dermatitis, Atopic / pathology
Eosinophils / immunology
Eosinophils / pathology
Humans
Immunoglobulin E / blood
Omalizumab / therapeutic use*
Severity of Illness Index

Substances

Adrenal Cortex Hormones
Anti-Allergic Agents
Antibodies, Monoclonal, Humanized
Calcineurin Inhibitors
Omalizumab
Immunoglobulin E
mepolizumab